<bill session="104" type="h" number="3691" updated="2013-07-14T18:48:20-04:00">
  <state datetime="1996-06-20">REFERRED</state>
  <status>
    <introduced datetime="1996-06-20"/>
  </status>
  <introduced datetime="1996-06-20"/>
  <titles>
    <title as="introduced" type="short">Prescription Drug Consumer Protection Act of 1996</title>
    <title as="introduced" type="official">To provide for the establishment of a Prescription Drug Price Review Board to identify excessive drug prices, and for other purposes.</title>
  </titles>
  <sponsor id="300058"/>
  <cosponsors>
    <cosponsor id="400387" joined="1996-09-12"/>
    <cosponsor id="400509" joined="1996-09-17"/>
    <cosponsor id="411947" joined="1996-09-12"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="1996-06-20">
      <text>Referred to the House Committee on Commerce.</text>
    </action>
    <action datetime="1996-06-28">
      <text>Referred to the Subcommittee on Health and Environment.</text>
      <committee name="House Committee on Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Drugs"/>
    <term name="Administrative procedure"/>
    <term name="Administrative remedies"/>
    <term name="Advice and consent of the Senate"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Consumer education"/>
    <term name="Costs"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug industry"/>
    <term name="Drugstores"/>
    <term name="Economics and public finance"/>
    <term name="Executive reorganization"/>
    <term name="Foreign trade and international finance"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Government publications"/>
    <term name="Government publicity"/>
    <term name="Governmental investigations"/>
    <term name="Health"/>
    <term name="Independent regulatory commissions"/>
    <term name="Intellectual property"/>
    <term name="International affairs"/>
    <term name="Law"/>
    <term name="Marketing"/>
    <term name="Medicare"/>
    <term name="Patent licenses"/>
    <term name="Patents"/>
    <term name="Pharmaceutical research"/>
    <term name="Prescription pricing"/>
    <term name="Presidential appointments"/>
    <term name="Price indexes"/>
    <term name="Price regulation"/>
    <term name="Product counterfeiting"/>
    <term name="Product safety"/>
    <term name="Public meetings of administrative bodies"/>
    <term name="Research and development"/>
    <term name="Restrictive trade practices"/>
    <term name="Sanctions (International law)"/>
    <term name="Science, technology, communications"/>
    <term name="Social welfare"/>
    <term name="Subpoena"/>
  </subjects>
  <amendments/>
  <summary>6/20/1996--Introduced.
Prescription Drug Consumer Protection Act of 1996 - Establishes in the executive branch the Prescription Drug Price Review Board which shall review the prices of prescription drugs. Permits the Board, after notice and a hearing, to take such actions as may be necessary to revoke a drug patent, if the drug's manufacturer does not reduce the price of a drug found to have an excessive price.</summary>
</bill>
